NULEXA : ultra-fast multiplex PCR
LEX Diagnostics is now QuidelOrtho
LEX Diagnostics is now QuidelOrtho and the VELO System is now the NULEXA™ System under QuidelOrtho
The CLIA waived NULEXA system brings together high speed and high sensitivity in a PCR molecular system that redefines point-of-care diagnostics. With less than one minute hands-on time, NULEXA Influenza + SARS Test completes tests in under 10 minutes and reports positive results in as little as 6 minutes. NULEXA Influenza + SARS Test provides lab quality results while patients wait.
The NULEXA Influenza + SARS Test reports positive results in as little as 6 minutes with multiplex detection and differentiation of Flu A, Flu B and COVID-19. Cleared for use in healthcare facilities operating under a CLIA Certificate of Waiver, the NULEXA system has a fully automated swab-to-result workflow that requires no swab elution, liquid sample handling or result interpretation. This eliminates hands-on time and provides results when you need them. The compact footprint is intended for use at the point of care in a physician’s office, pharmacy or urgent care facility.
The NULEXA test menu will soon expand to include StrepA, RSV and STIs.